Wangxi Hai
Impact in
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications
- Nanoparticle-Based Drug Delivery
Papers in
-
- Protease and Inhibitor Mechanisms 4
- Co-authors
- Maoquan Chu (2 shared papers)Ding Zhang (2 shared papers)Jinliang Peng (8 shared papers)Qiang Wu (1 shared paper)Xiaojing Pan (1 shared paper)Biao Li (21 shared papers)Xiaohang Qian (2 shared papers)Xufeng Jiang (2 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (4 papers)Biomaterials (2 papers)PLoS ONE (2 papers)International Journal of Pharmaceutics (1 paper)Clinical and Translational Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Wangxi Hai
38 papers receiving 924 citations
Peers
Comparison fields: 5 of 105
- Biomaterials 142
- Biological Psychiatry 19
- Biomedical Engineering 256
- Oncology 114
- Neurology 32
Countries citing papers authored by Wangxi Hai
This map shows the geographic impact of Wangxi Hai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangxi Hai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangxi Hai more than expected).
Fields of papers citing papers by Wangxi Hai
This network shows the impact of papers produced by Wangxi Hai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangxi Hai. The network helps show where Wangxi Hai may publish in the future.
Co-authors
The 25 scholars most cited alongside Wangxi Hai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 135 | |
| 2 | 2021 | 112 | |
| 3 | 2016 | 84 | |
| 4 | 2023 | 76 | |
| 5 | 2024 | 67 | |
| 6 | 2022 | 57 | |
| 7 | 2013 | 45 | |
| 8 | 2022 | 37 | |
| 9 | 2023 | 29 | |
| 10 | 2023 | 27 | |
| 11 | 2019 | 25 | |
| 12 | 2023 | 23 | |
| 13 | 2015 | 23 | |
| 14 | 2022 | 22 | |
| 15 | 2023 | 20 | |
| 16 | 2023 | 20 | |
| 17 | 2015 | 20 | |
| 18 | 2024 | 17 | |
| 19 | 2016 | 13 | |
| 20 | 2022 | 13 |
About Wangxi Hai
Wangxi Hai is a scholar working on Immunology, Cancer Research, Oncology, Physiology and Biomaterials, having authored 42 papers that have together received 929 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Peptidase Inhibition and Analysis (5 papers), Protease and Inhibitor Mechanisms (4 papers), Nanocluster Synthesis and Applications (4 papers), Autoimmune Neurological Disorders and Treatments (3 papers), Advanced biosensing and bioanalysis techniques (3 papers), Electrospun Nanofibers in Biomedical Applications (2 papers) and Advanced Nanomaterials in Catalysis (2 papers). The work is most often cited by research in Biomaterials (142 citations), Biological Psychiatry (19 citations), Biomedical Engineering (256 citations), Oncology (114 citations) and Neurology (32 citations). Wangxi Hai has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Maoquan Chu, Ding Zhang, Jinliang Peng, Qiang Wu, Xiaojing Pan, Biao Li, Xiaohang Qian, Xufeng Jiang, Huidong Tang and Shixing Huang. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Biomaterials, PLoS ONE, International Journal of Pharmaceutics and Clinical and Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.